99 related articles for article (PubMed ID: 26523771)
1. Repurposing historical control clinical trial data to provide safety context.
Bhuyan P; Desai J; Louis MS; Carlsson M; Bowen E; Danielson M; Cantor MN
Drug Discov Today; 2016 Feb; 21(2):212-6. PubMed ID: 26523771
[TBL] [Abstract][Full Text] [Related]
2. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
Renner M; Anliker B; Sanzenbacher R; Schuele S
Adv Exp Med Biol; 2015; 871():87-101. PubMed ID: 26374214
[TBL] [Abstract][Full Text] [Related]
4. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
Lucas-Samuel S; Ferry N; Trouvin JH
Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
[TBL] [Abstract][Full Text] [Related]
5. The sumatriptan/naratriptan aggregated patient (SNAP) database: aggregation, validation and application.
Barrows C; Saunders W; Austin R; Putnam G; Mansbach H;
Cephalalgia; 2004 Jul; 24(7):586-95. PubMed ID: 15196301
[TBL] [Abstract][Full Text] [Related]
6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
7. Clinical safety evaluation of combination vaccines.
Midthun K; Horne AD; Goldenthal KL
Dev Biol Stand; 1998; 95():245-9. PubMed ID: 9855438
[TBL] [Abstract][Full Text] [Related]
8. Sample size calculation based on efficient unconditional tests for clinical trials with historical controls.
Shan G; Moonie S; Shen J
J Biopharm Stat; 2016; 26(2):240-9. PubMed ID: 25551261
[TBL] [Abstract][Full Text] [Related]
9. An efficient delivery of historical information for the Mendelian Inheritance in Man database.
Li P; Waldo D; Pineo S; Foster P
Proc Annu Symp Comput Appl Med Care; 1995; ():127-31. PubMed ID: 8563251
[TBL] [Abstract][Full Text] [Related]
10. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
[TBL] [Abstract][Full Text] [Related]
11. Pediatric cardiovascular safety: challenges in drug and device development and clinical application.
Bates KE; Vetter VL; Li JS; Cummins S; Aguel F; Almond C; Dubin AM; Elia J; Finkle J; Hausner EA; Joseph F; Karkowsky AM; Killeen M; Lemacks J; Mathis L; McMahon AW; Pinnow E; Rodriguez I; Stockbridge NL; Stockwell M; Tassinari M; Krucoff MW
Am Heart J; 2012 Oct; 164(4):481-92. PubMed ID: 23067905
[TBL] [Abstract][Full Text] [Related]
12. Methods for observational post-licensure medical product safety surveillance.
Nelson JC; Cook AJ; Yu O; Zhao S; Jackson LA; Psaty BM
Stat Methods Med Res; 2015 Apr; 24(2):177-93. PubMed ID: 22138688
[TBL] [Abstract][Full Text] [Related]
13. [Clinical safety data management in company non-sponsored trials].
Saito A; Sakai J; Kurihara M; Kami M; Kanda Y; Mori S; Takaue Y; Ohashi Y
Nihon Rinsho; 2003 Sep; 61(9):1658-65. PubMed ID: 14515738
[TBL] [Abstract][Full Text] [Related]
14. How can the quality of medical data in pharmacovigilance, pharmacoepidemiology and clinical studies be guaranteed?
Alla F; Rosilio M; Funck-Brentano C; ; Barthélémy P; Brisset S; Cellier D; Chassany O; Demarez JP; Diebolt V; Francillon A; Gambotti L; Hannachi H; Lechat P; Lemaire F; Lièvre M; Misse C; Nguon M; Pariente A; Rosenheim M; Weisslinger-Darmon N
Therapie; 2013; 68(4):209-23. PubMed ID: 23981258
[TBL] [Abstract][Full Text] [Related]
15. A method to determine stroke trial success using multidimensional pooled control functions.
Mandava P; Kent TA
Stroke; 2009 May; 40(5):1803-10. PubMed ID: 19286598
[TBL] [Abstract][Full Text] [Related]
16. Analysis of safety data in clinical trials using a recurrent event approach.
Gong Q; Tong B; Strasak A; Fang L
Pharm Stat; 2014; 13(2):136-44. PubMed ID: 24519954
[TBL] [Abstract][Full Text] [Related]
17. [Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)].
Vos EJ; Huitema AD
Ned Tijdschr Geneeskd; 2006 Sep; 150(38):2104-7. PubMed ID: 17036864
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of historical data in the analysis of randomized therapeutic trials.
Rietbergen C; Klugkist I; Janssen KJ; Moons KG; Hoijtink HJ
Contemp Clin Trials; 2011 Nov; 32(6):848-55. PubMed ID: 21729767
[TBL] [Abstract][Full Text] [Related]
19. BayesWeb: a user-friendly platform for exploratory Bayesian analysis of safety signals from small clinical trials.
Scott JA; Hand AL; Sian LS
J Biopharm Stat; 2011 Sep; 21(5):1030-41. PubMed ID: 21830929
[TBL] [Abstract][Full Text] [Related]
20. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
